BP003579: Cynomolgus IFN alpha/beta R1 Protein with the C-His Tag
Source: The recombinant Cynomolgus IFN alpha/beta R1 Protein, (amino acids Ala25-Lys437) fused with a His tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Cynomolgus IFN alpha/beta R1 protein with the C-His tag at 1 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-IFNAR1 Antibody protein with the C-hFc tag with the EC50 of 0.42 ug/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP000082-GD27: Recombinant Human IFN alpha 2a (IFNA2) Protein
Source: E. coli-derived.
The specific activity as determined by a viral resistance assay using VSV-WISH cells was found to be 1.0 x 10^8 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000082-GD27: Recombinant Human IFN alpha 2a (IFNA2) Protein
Source: E. coli-derived.
The specific activity as determined by a viral resistance assay using VSV-WISH cells was found to be 1.0 x 10^8 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000082-GD27: Recombinant Human IFN alpha 2a (IFNA2) Protein
Source: E. coli-derived.
The specific activity as determined by a viral resistance assay using VSV-WISH cells was found to be 1.0 x 10^8 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000083-C005: Recombinant Human IFNα 2b Protein
Source: E. coli-derived.
The specific activity as determined in a viral resistance assay using VSV- WISH cells was found to be greater than 1.0 x 108 IU/ mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).- BP000085-CYT-135: Recombinant Human Interferon-alpha 14 (IFNA14) Protein
Source: E. coli-derived.
Purity > 90% as determined by SDS-PAGE. BP000083-C007: Recombinant Human IFNα 2b Pegylated
Source: E. coli-derived.
The specific activity as determined in a viral resistance assay using VSV-WISH cells was found to be 1.0 x 106 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP001372-C662: Recombinant Human IFN-alpha-6 (IFNA6) Protein
Source: HEK 293-derived.
Purity > 95% by reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP001373-C358: Recombinant Human Interferon Alpha/Beta Receptor 1 (IFNAR1) Protein
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000083-GD25: Recombinant Human IFNα 2b Protein
Source: E. coli-derived.
The specific activity as determined by a viral resistance assay using VSV-WISH cells was found to be 1.0 x 10^8 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).